These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 10450753)

  • 1. Phenylbutyrate-induced G1 arrest and apoptosis in myeloid leukemia cells: structure-function analysis.
    DiGiuseppe JA; Weng LJ; Yu KH; Fu S; Kastan MB; Samid D; Gore SD
    Leukemia; 1999 Aug; 13(8):1243-53. PubMed ID: 10450753
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Augmentation of phenylbutyrate-induced differentiation of myeloid leukemia cells using all-trans retinoic acid.
    Yu KH; Weng LJ; Fu S; Piantadosi S; Gore SD
    Leukemia; 1999 Aug; 13(8):1258-65. PubMed ID: 10450755
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of the putative differentiating agents sodium phenylbutyrate and sodium phenylacetate on proliferation, differentiation, and apoptosis of primary neoplastic myeloid cells.
    Gore SD; Samid D; Weng LJ
    Clin Cancer Res; 1997 Oct; 3(10):1755-62. PubMed ID: 9815560
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phenylbutyrate and phenylacetate induce differentiation and inhibit proliferation of human medulloblastoma cells.
    Li XN; Parikh S; Shu Q; Jung HL; Chow CW; Perlaky L; Leung HC; Su J; Blaney S; Lau CC
    Clin Cancer Res; 2004 Feb; 10(3):1150-9. PubMed ID: 14871995
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence of a functional role for the cyclin-dependent kinase inhibitor p21(WAF1/CIP1/MDA6) in the reciprocal regulation of PKC activator-induced apoptosis and differentation in human myelomonocytic leukemia cells.
    Wang Z; Su ZZ; Fisher PB; Wang S; VanTuyle G; Grant S
    Exp Cell Res; 1998 Oct; 244(1):105-16. PubMed ID: 9770354
    [TBL] [Abstract][Full Text] [Related]  

  • 6. G(1) Phase growth arrest and induction of p21(Waf1/Cip1/Sdi1) in IB3-1 cells treated with 4-sodium phenylbutyrate.
    McGrath-Morrow SA; Stahl JL
    J Pharmacol Exp Ther; 2000 Sep; 294(3):941-7. PubMed ID: 10945844
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sequence-dependent antitumor effects of differentiation agents in combination with cell cycle-dependent cytotoxic drugs.
    Verheul HM; Qian DZ; Carducci MA; Pili R
    Cancer Chemother Pharmacol; 2007 Aug; 60(3):329-39. PubMed ID: 17256134
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A small-molecule c-Myc inhibitor, 10058-F4, induces cell-cycle arrest, apoptosis, and myeloid differentiation of human acute myeloid leukemia.
    Huang MJ; Cheng YC; Liu CR; Lin S; Liu HE
    Exp Hematol; 2006 Nov; 34(11):1480-9. PubMed ID: 17046567
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship between cyclin D1 and p21(Waf1/Cip1) during differentiation of human myeloid leukemia cell lines.
    Ullmannová V; Stöckbauer P; Hradcová M; Soucek J; Haskovec C
    Leuk Res; 2003 Dec; 27(12):1115-23. PubMed ID: 12921950
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [5-Aza-2'-deoxycytidine enhances differentiation and apoptosis induced by phenylbutyrate in Kasumi-1 cells].
    Hao CL; Tang KJ; Chen S; Xing HY; Wang M; Wang JX
    Zhonghua Zhong Liu Za Zhi; 2005 Mar; 27(3):148-51. PubMed ID: 15946563
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vulnerability of multidrug-resistant tumor cells to the aromatic fatty acids phenylacetate and phenylbutyrate.
    Shack S; Miller A; Liu L; Prasanna P; Thibault A; Samid D
    Clin Cancer Res; 1996 May; 2(5):865-72. PubMed ID: 9816242
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phenylbutyrate induces apoptosis in human prostate cancer and is more potent than phenylacetate.
    Carducci MA; Nelson JB; Chan-Tack KM; Ayyagari SR; Sweatt WH; Campbell PA; Nelson WG; Simons JW
    Clin Cancer Res; 1996 Feb; 2(2):379-87. PubMed ID: 9816181
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulation of radiation response of human tumour cells by the differentiation inducers, phenylacetate and phenylbutyrate.
    Miller AC; Whittaker T; Thibault A; Samid D
    Int J Radiat Biol; 1997 Aug; 72(2):211-8. PubMed ID: 9269314
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction of apoptosis in malignant B cells by phenylbutyrate or phenylacetate in combination with chemotherapeutic agents.
    Witzig TE; Timm M; Stenson M; Svingen PA; Kaufmann SH
    Clin Cancer Res; 2000 Feb; 6(2):681-92. PubMed ID: 10690554
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of the putative differentiating agent sodium phenylbutyrate on myelodysplastic syndromes and acute myeloid leukemia.
    Gore SD; Weng LJ; Zhai S; Figg WD; Donehower RC; Dover GJ; Grever M; Griffin CA; Grochow LB; Rowinsky EK; Zabalena Y; Hawkins AL; Burks K; Miller CB
    Clin Cancer Res; 2001 Aug; 7(8):2330-9. PubMed ID: 11489809
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effect of phenylbutyrate, a histone deacetylase inhibitor, on differentiation and apoptosis of Kasumi-1 cells].
    Hao CL; Tang KJ; Tian Z; Xing HY; Wang M; Wang JX
    Zhonghua Xue Ye Xue Za Zhi; 2003 May; 24(5):241-4. PubMed ID: 12859874
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of phenylbutyrate on proliferation and apoptosis in human prostate cancer cells in vitro and in vivo.
    Melchior SW; Brown LG; Figg WD; Quinn JE; Santucci RA; Brunner J; Thüroff JW; Lange PH; Vessella RL
    Int J Oncol; 1999 Mar; 14(3):501-8. PubMed ID: 10024683
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Apoptosis and tumor remission in liver tumor xenografts by 4-phenylbutyrate.
    Svechnikova I; Gray SG; Kundrotiene J; Ponthan F; Kogner P; Ekström TJ
    Int J Oncol; 2003 Mar; 22(3):579-88. PubMed ID: 12579311
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The histone deacetylase inhibitor MS-275 promotes differentiation or apoptosis in human leukemia cells through a process regulated by generation of reactive oxygen species and induction of p21CIP1/WAF1 1.
    Rosato RR; Almenara JA; Grant S
    Cancer Res; 2003 Jul; 63(13):3637-45. PubMed ID: 12839953
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increases in NMR-visible lipid and glycerophosphocholine during phenylbutyrate-induced apoptosis in human prostate cancer cells.
    Milkevitch M; Shim H; Pilatus U; Pickup S; Wehrle JP; Samid D; Poptani H; Glickson JD; Delikatny EJ
    Biochim Biophys Acta; 2005 May; 1734(1):1-12. PubMed ID: 15866478
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.